Русский
State of the nephrological service: renal replacement therapy in the Russian Federation from 2015 to 2019
DOI: https://dx.doi.org/10.18565/nephrology.2020.1.6-14
E.M. Shilov, O.N. Kotenko, M.M. Shilova, K.S. Milchakov, M.A. Gabaev, R.A. Khalfin
1) Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; 2) Peoples’ Friendship University of Russia, Moscow, Russia; 3) Pirogov Russian National Research Medical University, Moscow, Russia; 4) Sechenov First Moscow State Medical University (Sechenov University), Higher School of Healthcare Management, Institute of Leadership and Healthcare Management, Moscow, Russia
Background. Chronic kidney disease (CKD) is a serious medical and socio-economic problem in the Russian Federation (RF). Competent primary and secondary prevention of CKD along with adequate provision of renal replacement therapy (RRT) to the population are the key to reducing mortality, frequency of complications, disease progression rate and the treatment cost.
Problem. Over the past ten years, the provision of RRT to the population of the Russian Federation has increased, but at the moment it still does not correspond to the real need for it, which is associated with both insufficient rates of RRT development and low detection of CKD patients. Lack of secondary prevention, qualified personnel shortage and untimely primary diagnostics lead to a high prevalence of end-stage CKD and an increase in treatment costs.
Objective. This article reflects the trends in RRT development in the Russian Federation for the period 2015-2019 according to the Report of the Russian Dialysis Society and the Reports of the Russian Transplant Society, as well as new data from the specialized commission of the Expert Council on Nephrology of the Ministry of Health of the Russian Federation.
Conclusion. The RRT system in the Russian Federation has been continuously developing since 1998, however, there are still serious differences in the availability of RRT between the regions of the country. A number of parameters of medical care for patients with end-stage CKD still require close attention: the availability of RRT and simultaneously improved screening systems for CKD in risk groups, clarification of the government statistics system, improving the quality of drug provision for patients with end-stage CKD and the development of the transplantation system.
Problem. Over the past ten years, the provision of RRT to the population of the Russian Federation has increased, but at the moment it still does not correspond to the real need for it, which is associated with both insufficient rates of RRT development and low detection of CKD patients. Lack of secondary prevention, qualified personnel shortage and untimely primary diagnostics lead to a high prevalence of end-stage CKD and an increase in treatment costs.
Objective. This article reflects the trends in RRT development in the Russian Federation for the period 2015-2019 according to the Report of the Russian Dialysis Society and the Reports of the Russian Transplant Society, as well as new data from the specialized commission of the Expert Council on Nephrology of the Ministry of Health of the Russian Federation.
Conclusion. The RRT system in the Russian Federation has been continuously developing since 1998, however, there are still serious differences in the availability of RRT between the regions of the country. A number of parameters of medical care for patients with end-stage CKD still require close attention: the availability of RRT and simultaneously improved screening systems for CKD in risk groups, clarification of the government statistics system, improving the quality of drug provision for patients with end-stage CKD and the development of the transplantation system.
